Cited 11 time in
Triglyceride and glucose index is a simple and easy-to-calculate marker associated with nonalcoholic fatty liver disease
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Kyung-Soo | - |
| dc.contributor.author | Hong, Sangmo | - |
| dc.contributor.author | Ahn, Hong-Yup | - |
| dc.contributor.author | Park, Cheol-Young | - |
| dc.date.accessioned | 2023-04-27T11:40:33Z | - |
| dc.date.available | 2023-04-27T11:40:33Z | - |
| dc.date.issued | 2022-06 | - |
| dc.identifier.issn | 1930-7381 | - |
| dc.identifier.issn | 1930-739X | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/3099 | - |
| dc.description.abstract | Objective The aim of this study was to evaluate the relationship between the triglyceride and glucose (TyG) index and nonalcoholic fatty liver disease (NAFLD) using a large, population-based cohort study database. Methods A total of 52,575 participants were enrolled from 2007 to 2013 in the Kangbuk Samsung Health Study cohort. The presence of NAFLD was ascertained by ultrasonography in the absence of other known liver diseases. Results Over a median 5.1 years of follow-up, 7,292 participants (13.87%) were diagnosed with NAFLD. In a multivariate-adjusted model, the hazard ratio for NAFLD of the TyG index was 1.413 (95% CI: 1.349-1.480) in the first 6 months, 1.480 (95% CI: 1.408-1.556) in months 6 to 12, 1.427 (95% CI: 1.370-1.485) in months 12 to 18, and 1.246 (95% CI: 1.159-1.339) in months >18. The hazard ratios of triglycerides, glucose, fatty liver index, and homeostatic model assessment of insulin resistance for NAFLD in months >18 were 1.124 (95% CI: 1.061-1.190), 1.037 (95% CI: 0.970-1.109), 1.508 (95% CI: 1.417-1.605), and 1.177 (95% CI: 1.116-1.242), respectively. The NAFLD-free rate decreased with increasing TyG index quartile (p < 0.001). The TyG index level from which the risk of NAFLD increased appeared to be 8.24. Conclusions This study found that the TyG index is a simple and easy-to-calculate marker associated with NAFLD. | - |
| dc.format.extent | 10 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Wiley | - |
| dc.title | Triglyceride and glucose index is a simple and easy-to-calculate marker associated with nonalcoholic fatty liver disease | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1002/oby.23438 | - |
| dc.identifier.scopusid | 2-s2.0-85131363549 | - |
| dc.identifier.wosid | 000807659100020 | - |
| dc.identifier.bibliographicCitation | Obesity, v.30, no.6, pp 1279 - 1288 | - |
| dc.citation.title | Obesity | - |
| dc.citation.volume | 30 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 1279 | - |
| dc.citation.endPage | 1288 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
| dc.relation.journalResearchArea | Nutrition & Dietetics | - |
| dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
| dc.relation.journalWebOfScienceCategory | Nutrition & Dietetics | - |
| dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
| dc.subject.keywordPlus | HOMA-IR | - |
| dc.subject.keywordPlus | METABOLIC SYNDROME | - |
| dc.subject.keywordPlus | INDIVIDUALS | - |
| dc.subject.keywordPlus | LIMITATIONS | - |
| dc.subject.keywordPlus | MANAGEMENT | - |
| dc.subject.keywordPlus | MORTALITY | - |
| dc.subject.keywordPlus | DIAGNOSIS | - |
| dc.subject.keywordPlus | PREDICT | - |
| dc.subject.keywordPlus | RISK | - |
| dc.subject.keywordAuthor | Alanine Aminotransferase | - |
| dc.subject.keywordAuthor | Aspartate Aminotransferase | - |
| dc.subject.keywordAuthor | Creatinine | - |
| dc.subject.keywordAuthor | Gamma Glutamyltransferase | - |
| dc.subject.keywordAuthor | Glycosylated Hemoglobin | - |
| dc.subject.keywordAuthor | Glucose | - |
| dc.subject.keywordAuthor | Biomarkers | - |
| dc.subject.keywordAuthor | Blood Glucose | - |
| dc.subject.keywordAuthor | Glucose | - |
| dc.subject.keywordAuthor | Triglycerides | - |
| dc.subject.keywordAuthor | Adiva 1800 | - |
| dc.subject.keywordAuthor | Logic Q700 | - |
| dc.subject.keywordAuthor | Alanine Aminotransferase | - |
| dc.subject.keywordAuthor | Apolipoprotein A1 | - |
| dc.subject.keywordAuthor | Apolipoprotein B | - |
| dc.subject.keywordAuthor | Aspartate Aminotransferase | - |
| dc.subject.keywordAuthor | Creatinine | - |
| dc.subject.keywordAuthor | Gamma Glutamyltransferase | - |
| dc.subject.keywordAuthor | Glycosylated Hemoglobin | - |
| dc.subject.keywordAuthor | High Density Lipoprotein Cholesterol | - |
| dc.subject.keywordAuthor | Triacylglycerol | - |
| dc.subject.keywordAuthor | Biological Marker | - |
| dc.subject.keywordAuthor | Glucose | - |
| dc.subject.keywordAuthor | Adult | - |
| dc.subject.keywordAuthor | Article | - |
| dc.subject.keywordAuthor | Diastolic Blood Pressure | - |
| dc.subject.keywordAuthor | Echography | - |
| dc.subject.keywordAuthor | Female | - |
| dc.subject.keywordAuthor | Glucose Blood Level | - |
| dc.subject.keywordAuthor | Glucose Tolerance | - |
| dc.subject.keywordAuthor | Homeostasis Model Assessment | - |
| dc.subject.keywordAuthor | Human | - |
| dc.subject.keywordAuthor | Hypercholesterolemia | - |
| dc.subject.keywordAuthor | Hypertension | - |
| dc.subject.keywordAuthor | Insulin Resistance | - |
| dc.subject.keywordAuthor | Male | - |
| dc.subject.keywordAuthor | Nonalcoholic Fatty Liver | - |
| dc.subject.keywordAuthor | Questionnaire | - |
| dc.subject.keywordAuthor | Systolic Blood Pressure | - |
| dc.subject.keywordAuthor | Triglyceride-glucose Index | - |
| dc.subject.keywordAuthor | Waist Circumference | - |
| dc.subject.keywordAuthor | Cohort Analysis | - |
| dc.subject.keywordAuthor | Diagnostic Imaging | - |
| dc.subject.keywordAuthor | Risk Factor | - |
| dc.subject.keywordAuthor | Biomarkers | - |
| dc.subject.keywordAuthor | Blood Glucose | - |
| dc.subject.keywordAuthor | Cohort Studies | - |
| dc.subject.keywordAuthor | Glucose | - |
| dc.subject.keywordAuthor | Humans | - |
| dc.subject.keywordAuthor | Non-alcoholic Fatty Liver Disease | - |
| dc.subject.keywordAuthor | Risk Factors | - |
| dc.subject.keywordAuthor | Triglycerides | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
